Genetics Indonesia

What Genetics Indonesia does

Genetics Indonesia is a privately held Indonesian biotechnology company, founded in 2016 and headquartered in Jakarta, that describes its focus as molecular genetics. The company's profile states 11-50 employees and a for-profit structure, but no products, services, technology stack, intellectual property, or laboratory capabilities are disclosed in the available source material.

The firm's only named leader is Simon Wong, founder and director. No further management, scientific advisory, or operational personnel are identified in the input. Genetics Indonesia's own website (geneticsindonesia.com) currently serves an Apache2 Ubuntu default placeholder page rather than company content, and no revenue, funding, partnership, certification, customer, awards, or pricing data is available. As a result, the underlying business model — what assays or services are offered, to whom, at what price, and through what channel — cannot be determined from the input.

Given the firmographic anchors (molecular genetics, Indonesian biotech, 11-50 headcount, founded 2016, private, Jakarta), plausible operating interpretations include a clinical or research-grade genetics/diagnostics services provider, a distributor of molecular biology products, or an early-stage laboratory venture. None of these can be confirmed against the supplied evidence, and the analyst should treat the entity as data-thin until first-party disclosures become available.

Name

Genetics Indonesia

Website

https://geneticsindonesia.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Genetics Indonesia is a privately held, Jakarta-based biotechnology company founded in 2016 that focuses on molecular genetics, operating with 11-50 employees. The company does not publicly disclose its specific products, services, customers, or revenue.

Ownership category

akta.pro rank

Product category

Molecular Genetics Biotechnology Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industry

Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

• Molecular genetics services
• Biotechnology research
• Genetic testing
• DNA analysis
• Molecular diagnostics

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

Genetics Indonesia operates as a biotechnology company whose stated focus is molecular genetics. No further product, service, or commercial detail is evidenced in the provided source material because the company website currently displays only a default Apache2 Ubuntu server page, and no additional offerings are described in the aggregated input.

Differentiator

Problem solved

Functional benefit

Products and services

• Molecular genetics services

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights1 record

Broad incumbents

• BGI Genomics: One of the world's largest genomics organizations with significant Asia-Pacific operations. Sets the competitive baseline for scale, pricing, and capacity in regional molecular genetics services.
• Novogene: Global genomics services provider with Asia-Pacific headquarters and sequencing/bioinformatics capabilities. Comparable as a scaled provider competing for institutional and research customers in the same geography.
• Eurofins Genomics: Global genomics services division of Eurofins Scientific offering DNA sequencing, genotyping, and molecular biology services. Relevant incumbent that regional molecular genetics labs must compete against on price and turnaround.

Emerging players

• Strand Life Sciences: India-based genomics and clinical diagnostics company with bioinformatics capabilities. Comparable as a regional emerging-market molecular genetics and diagnostics operator pursuing similar customer segments.
• Dxome (Prenetics): Asia-focused molecular diagnostics provider offering genetic and infectious disease testing. Comparable as a regional emerging player in molecular genetics services serving institutional and clinical customers.

Direct peers

• Genomik Solidaritas Indonesia (GSI Lab): Indonesian genomics and molecular diagnostics laboratory known for COVID-19 testing and broader genetic services. Closest domestic peer in terms of geography, scale, and molecular genetics service offering.
• Yourgene Health: Molecular diagnostics company specializing in genetic testing, reproductive health, and oncology genomics. Comparable as a molecular genetics service provider targeting clinical and research customers in Asia-Pacific.
• Nusantics: Indonesia-based molecular biotechnology company focused on microbiome and genomic diagnostics. Directly comparable to Genetics Indonesia as a fellow Indonesian molecular biology/genetics services company serving regional healthcare and research markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/geneticsindonesia

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetics Indonesia